U.S. flag

An official website of the United States government

NM_004064.5(CDKN1B):c.-31AG[1] AND not provided

Germline classification:
Conflicting interpretations of pathogenicity (2 submissions)
Last evaluated:
Jun 13, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000994850.33

Allele description [Variation Report for NM_004064.5(CDKN1B):c.-31AG[1]]

NM_004064.5(CDKN1B):c.-31AG[1]

Gene:
CDKN1B:cyclin dependent kinase inhibitor 1B [Gene - OMIM - HGNC]
Variant type:
Microsatellite
Cytogenetic location:
12p13.1
Genomic location:
Preferred name:
NM_004064.5(CDKN1B):c.-31AG[1]
HGVS:
  • NC_000012.11:g.12870742_12870745delGAGA
  • NC_000012.12:g.12717809AG[1]
  • NG_016341.1:g.5442AG[1]
  • NM_004064.5:c.-31AG[1]MANE SELECT
  • NC_000012.11:g.12870742_12870745del
  • NC_000012.11:g.12870742_12870745delGAGA
  • NC_000012.11:g.12870743AG[1]
  • NC_000012.12:g.12717808_12717811delGAGA
  • NM_004064.3:c.-29_-26delAGAG
  • NM_004064.4:c.-29_-26delAGAG
  • NM_004064.5:c.-29_-26delAGAGMANE SELECT
Links:
OMIM: 600778.0004; dbSNP: rs774454456
NCBI 1000 Genomes Browser:
rs774454456
Molecular consequence:
  • NM_004064.5:c.-31AG[1] - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
Observations:
10

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001148641CeGaT Center for Human Genetics Tuebingen
criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)
Likely benign
(Sep 1, 2023)
germlineclinical testing

Citation Link,

SCV002319178GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Uncertain significance
(Jun 13, 2024)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes10not providednot providednot providednot providedclinical testing

Details of each submission

From CeGaT Center for Human Genetics Tuebingen, SCV001148641.26

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided10not providednot providedclinical testingnot provided

Description

CDKN1B: PS3:Moderate, BP4, BS1

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided10not providednot providednot provided

From GeneDx, SCV002319178.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Published functional studies demonstrate a damaging effect: decreased transcriptional activity, reduced p27 mRNA, and increased cytoplasmic localization (PMID: 22129891, 25645465, 27038812); Identified in patients with clinical features of Multiple Endocrine Neoplasia syndrome type 4 (MEN4) in published literature, but inherited from an unaffected parent in at least one family (PMID: 22129891, 25645465, 27038812, 32232325); Deleted nucleotides are not conserved across species; Also known as c.-32_-29del; This variant is associated with the following publications: (PMID: 27038812, 28824003, 25645465, 26054904, 27657986, 24819502, 30555957, 32232325, 34426522, 30065701, 35355569, 30990521, 36520683, 22129891)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024